Michael Phoch
Americanstocknews - 20 years of experience in mass media
Perhaps the greatest by-product of tech advancement in healthcare has been our ability to create more personalized experiences patients want from their healthcare. Better understanding each patient’s ‘health continuum’ helps make this a reality, by leveraging data and insights to follow patients throughout their entire care journey – from hospital to home –so patients can
More
Sony Electronics Inc. today announced the debut of the Spatial Reality Display (SR Display), a groundbreaking new product made with Sony’s award-winning Eye-Sensing Light Field Display (ELFD) technology. The display, initially shared with attendees at the Consumer Electronics Show in January of this year, does not require virtual reality glasses or a headset1. The SR
More
Cellist Yo-Yo Ma and pianist Kathryn Stott come together again, this time for Songs of Comfort and Hope, set for release on December 11, 2020 on Sony Classical.
More
Philips delivers Q3 sales of EUR 5.0 billion, with 10% comparable sales growth; income from continuing operations increases to EUR 341 million, Adjusted EBITA margin improves 300 basis points to 15.4%, and operating cash flow increases to EUR 770 million
More
Countries in the Middle East and Central Asia face with COVID-19 a public health emergency unlike any seen in our lifetime, along with an unprecedented economic downturn. The pandemic is exacerbating existing economic and social challenges, calling for urgent action to mitigate the threat of long-term damage to incomes and growth.
More
Loan of US$ 25 million to support entrepreneurs amid coronavirus pandemic
Financing to support companies affected by economic impact of crisis
Funds will boost resilience of Turkey’s financial sector
On 7 October, the investigation service of the Dutch tax authorities, FIOD (Fiscale Inlichtingen en OpsporingsDienst), raided an illegal tobacco factory in West-Betuwe, south of Utrecht.
More
Shenzhen Stock Exchange (SZSE) and China Resources (Holdings) Co., Ltd. (CR) signed a strategic cooperation framework agreement.
More
Approval supported by data from phase III confirmatory trials, VIALE-A and VIALE-C
VIALE-A study showed Venclexta plus azacitidine significantly improved overall survival in newly diagnosed AML compared to azacitidine alone
Supplemental New Drug Applications approved under the FDA's Real-Time Oncology Review pilot programme and Project Orbis initiative
